Ami Organics Ltd
NSE:AMIORG

Watchlist Manager
Ami Organics Ltd Logo
Ami Organics Ltd
NSE:AMIORG
Watchlist
Price: 2 299.35 INR 7.6% Market Closed
Market Cap: 94.1B INR
Have any thoughts about
Ami Organics Ltd?
Write Note

Ami Organics Ltd
Other Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ami Organics Ltd
Other Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Assets CAGR 3Y CAGR 5Y CAGR 10Y
Ami Organics Ltd
NSE:AMIORG
Other Assets
â‚ą568m
CAGR 3-Years
47%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Other Assets
â‚ą13.2B
CAGR 3-Years
33%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Other Assets
â‚ą32.5B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
3%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Other Assets
â‚ą87.7B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
14%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Other Assets
â‚ą3.4B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
36%
M
Mankind Pharma Ltd
NSE:MANKIND
Other Assets
â‚ą200.2m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Ami Organics Ltd
Glance View

Market Cap
94.1B INR
Industry
Pharmaceuticals

Ami Organics Ltd. engages in the development and commercialization of pharmaceutical intermediate products. The company is headquartered in Surat, Gujarat and currently employs 561 full-time employees. The company went IPO on 2021-09-14. These specialty chemicals with varied end usage, focus on the development and manufacturing of pharma intermediates for regulated and generic active pharmaceutical ingredient (APIs) and new chemical entity (NCEs). The company manufactures pharma intermediates for certain APIs, including dolutegravir, trazodone, entacapone, nintedanib and rivaroxaban. The pharma intermediates, which the Company manufactures have application in certain high-growth therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant. The company has developed and commercialized over 450 pharma intermediates for APIs and NCEs across 17 therapeutic areas. Its specialty chemicals have applications in the agrochemicals and fine chemicals industries. The firm supplies its products to more than 150 customers directly in India.

AMIORG Intrinsic Value
1 495.1 INR
Overvaluation 35%
Intrinsic Value
Price

See Also

What is Ami Organics Ltd's Other Assets?
Other Assets
568m INR

Based on the financial report for Mar 31, 2024, Ami Organics Ltd's Other Assets amounts to 568m INR.

What is Ami Organics Ltd's Other Assets growth rate?
Other Assets CAGR 5Y
33%

Over the last year, the Other Assets growth was 179%. The average annual Other Assets growth rates for Ami Organics Ltd have been 47% over the past three years , 33% over the past five years .

Back to Top